Skip to main content
SpringerLink
Log in

Post-Remission Therapy for Acute Myelogenous Leukemia

  • Chapter
Chronic and Acute Leukemias in Adults

Part of the book series: Cancer Treatment and Research ((CTAR,volume 26))

Abstract

Over the past 25 years considerable progress has been made in the treatment of acute myelogenous leukemia (AML). Multiple factors have contributed to this success. These include the introduction of new drugs, the use of combination chemotherapy, a better understanding of the biology of the disease and bone marrow regeneration, improved supportive care including platelet and granulocyte transfusions and more effective antibiotics. As a result, complete remission rates of 80% have been obtained in some subsets of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Blom J, Leone LA, Haurani F, Kyle R, Hutchison JL, Forcier RJ, Moon JH: Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood 32:507–523, 1968.

    PubMed  CAS  Google Scholar 

  2. Boggs DR, Wintrobe MM, Cartwright GE. The acute leukemias: Analysis of 322 cases and review of the literature. Medicine 41:163–225, 1962.

    Article  PubMed  CAS  Google Scholar 

  3. Vogler WR, Huguley CM Jr, Rundles RW: Comparison of methotrexate with 6-mercaptopurine-prednisone in treatment of acute leukemia in adults. Cancer 20:1221–1226, 1967.

    Article  PubMed  CAS  Google Scholar 

  4. Ellison RR, Hoogstraten B, Holland JF, Levy RN, Lee SL, Silver RT, Leone LA, Cooper T, Oberfield RA, Pas A, Blom J, Jacquillet C, Haurani F: Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. Cancer Chemo Rep 56:535–542, 1972.

    CAS  Google Scholar 

  5. Thompson I, Hall TC, Maloney WC: Combination therapy of adult and acute myelogenous leukemia: Experience with the simultaneous use of vincristine, amethopterin, 6-mercaptopurine and prednisone. N Engl J Med 273:1302–1307, 1965.

    Article  PubMed  CAS  Google Scholar 

  6. Wiernik Ph, Serpick AA: A randomized trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine and methotrexate in adult acute non-lymphocytic leukemia. Cancer Res 32:2023–2026, 1972.

    PubMed  CAS  Google Scholar 

  7. Rodriguez V, Hart JS, Freireich EJ, Bodey GP, McCredie KB, Whitecar JP, Coltman CA JR: POMP combination chemotherapy of adult acute leukemia. Cancer 32:69–75. 1973.

    Article  PubMed  CAS  Google Scholar 

  8. Henderson ES: Treatment of acute leukemia. Ann Intern Med 69:628, 1968.

    PubMed  CAS  Google Scholar 

  9. Bodey GP, Freireich EJ, Monto RW, Hewlett JD: Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. Cancer Chemo Rep 53:59, 1969.

    CAS  Google Scholar 

  10. Bailey CC, Geary CG, Israels CG, Whittaker JA, Brown MJ, Weatherall DJ: Cytosine arabinoside in the treatment of acute myeloblastic leukemia. Lancet 1:1260–1271, 1971.

    Google Scholar 

  11. Goodell B, Leventhal B, Henderson E: Cytosine arabinoside in acute granulocytic leukemia. Clinical Pharm Thera 12:599–606, 1971.

    CAS  Google Scholar 

  12. Bodey GP, Coltman CA, Freireich EJ, Bonnet JD, Gehan EA, Haut AB, Hewlett JS, McCredie KB, Saiki Jh, Wilson HE: Chemotherapy of acute leukemia. Arch Intern Med 133:260–269, 1974.

    Article  PubMed  CAS  Google Scholar 

  13. Carey RW, Ribas-Mundo M, Ellison RR, Glidewell O, Lee ST, Cuttner J, Levy RN, Silver R, Blom J, Haurani F, Spurr CL, Harley JB, Kyle R, Moon JH, Eagan RT, Holland JH: Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Cancer 36:1560–1567, 1975.

    Article  PubMed  CAS  Google Scholar 

  14. Boiron M, Jacquillat C, Weil M, Tanzer J, Levy D, Sultan C, Bernard J: Daunorubicin in the treatment of acute myelocytic leukemia. Lancet 1:330–333, 1969.

    Article  PubMed  CAS  Google Scholar 

  15. Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon M-F: Acute promyelocytic leukemia: Results of treatment by daunorubicin. Blood 41:489–496, 1973.

    PubMed  CAS  Google Scholar 

  16. Cassileth PA, Katz ME: Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside. Cancer Treat Rep 61:1441–1445, 1977.

    PubMed  CAS  Google Scholar 

  17. Preisler HD, Rustum Y, Henderson ES, Bjornsson S, Creaven PJ, Higby DJ, Freeman A, Gailani S, Naeher C: Treatment of acute nonlymphocytia leukemia: Use of anthracycline-cystosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 53:455–459, 1979.

    PubMed  CAS  Google Scholar 

  18. Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Cooper MR, Haurani F, Hutchison JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, Mclntyre OR, Kaan SK: Treatment of acute myelocytic leukemia: A study of cancer and leukemia group B. Blood 58:1203–1212, 1981.

    PubMed  CAS  Google Scholar 

  19. Yaters J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchinson JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L. Holland JF: Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: A CALGB Study. Blood 60:454–462, 1982.

    Google Scholar 

  20. Vogler WR, Winton EF, Gordon DS, Jarrell R, Lefante J: Prognostic factors affecting remission induction and duration in adult acute myelogenous leukemia (AML). ASCO Proc 22:489, 1981.

    Google Scholar 

  21. Omura GA, Vogler WR, Lefante J, Silberman H, Knospe W, Gordon D, Jarrell R: Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy. Cancer 49:1530–1536, 1982.

    Article  PubMed  CAS  Google Scholar 

  22. Rees JKH, Sandler RM, Challenger J, Hayhoe FGJ: Treatment of acute myeloid leukaemia with a triple cytotoxic regimen: Dat. Br J Cancer 36:770–776, 1977.

    Article  PubMed  CAS  Google Scholar 

  23. Amadori S, Papa G, Meloni G, Pacilli L, Mandelli F: Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia. Leukemia Res 3:147–152, 1979.

    Article  CAS  Google Scholar 

  24. Peterson BA, Bloomfield CD, Bosl GJ, Gibbs G, Malloy M: Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia. Cancer 46:663–668, 1980.

    Article  PubMed  CAS  Google Scholar 

  25. Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E III: Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303:473–478, 1980.

    Article  PubMed  CAS  Google Scholar 

  26. Glucksberg H, Cheever MA, Farewell VT, Fefer A, Sale GE, Thomas ED: High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer 48:1073–1081, 1981.

    Article  PubMed  CAS  Google Scholar 

  27. Gale RP, Foon KA, Cline MJ, Zighelboim J, and the UCLA: Acute Leukemia Study Group. Intensive chemotherapy for acute myelogenous leukemia. Ann Intern Med 94:753–757, 1981.

    PubMed  CAS  Google Scholar 

  28. Armitage JO, Burns CP, Dick FR, Aunan SB, Slymen DJ: Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer Treat Rep 66:1917–1924, 1982.

    PubMed  CAS  Google Scholar 

  29. Southwest Oncology Group. Cytarabine for acute leukemia in adults. Arch Intern Med 133:251–259, 1974.

    Article  Google Scholar 

  30. Skell RT, Costello W, Bennett JM, Oken MM, Tobin MS, Bertino JR, Marsh JC, Carbone PP. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults. Cancer 45:224–231, 1980.

    Article  Google Scholar 

  31. Bell R, Rohatiner AZS, Slevin ML, Ford JM, Dhaliwal HS, Henry G, Birkhead BG, Amess JAL, Malpas JS, Lister TA: Short-term treatment for acute myelogenous leukaemia. British Med J 284:1221–1224, 1982.

    Article  CAS  Google Scholar 

  32. Keating MJ, Smith TL, McCredie KB, Bodey GP, Hersh EM, Gutterman JU, Gehan E, Freireich EJ: A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia. Cancer 47:2779–2788, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Peterson BA, Bloomfield CD: Long-term disease-free survival in acute nonlymphocytic leukemia. Blood 57:1144–1147, 1981.

    PubMed  CAS  Google Scholar 

  34. Boiron M, Jacquillat C, Marty M, Weil M, Gisselbrecht C: Anthracyclines in the treatment of acute nonlymphocytic leukemias. Cancer Treat Rep 65(suppl 4): 73–76, 1981.

    PubMed  Google Scholar 

  35. Frei E III, Holland JF, Schneiderman WA, Pinkel D, Selkirk G, Freireich EJ, Silver RT, Gold GL, Regelson W: A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood 13:1126–1148, 1958.

    PubMed  Google Scholar 

  36. Freireich EJ, Bodey GP, Harris JE, Hart JS: Therapy for acute granulocytic leukemia. Ca Res 27:2573–2577, 1967.

    CAS  Google Scholar 

  37. Vogler WR: Clinical trials of 1-beta-D-Arabinofuranosyl cytosine and l-3-bis-(2-chloroe-thyl)-l-nitrosourea combination in metastatic cancer and acute leukemia. Cancer 27:1081–1088, 1971.

    Article  PubMed  CAS  Google Scholar 

  38. Vogler WR, Chan Y-K: Prolonging remission in myeloblastic leukemia by tice-strain bacillus calmette guerin. Lancet 2:128–131, 1974.

    Article  PubMed  CAS  Google Scholar 

  39. Vogler WR, Bartolucci AA, Omura GA, Miller D, Smalley RV, Knospe WH, Goldsmith AS, Chan Y-K, Murphy S: Randomized clinical trial of remission induction, consolidation, and chemo-immunotherapy maintenance in adult acute myeloblastic leukemia. Cancer Immunol immunother 3:163–170, 1978.

    Article  Google Scholar 

  40. Vogler WR, Winton EF, Gordon DS, Lefante J, Raney M: A randomized trial of post-remission therapy in acute myeloid leukemia. ASCO Proc 1:138, 1982.

    Google Scholar 

  41. Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–1733, 1979.

    PubMed  CAS  Google Scholar 

  42. Goldie JH, Coldman AJ, Gudauskas GA: Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439–449, 1982.

    PubMed  CAS  Google Scholar 

  43. Embury SH, Elias L, Heller PH, Hood CE, Greenberg PL, Schrier SL: Remission maintenance therapy in acute myelogenous leuemia. W J Med 126:267–272, 1977.

    CAS  Google Scholar 

  44. Vogler WR, Gordon DS, Smalley RV, Heffner LT, Trulock P, Guzman G, Barbieri B, Hearn E: Serial immunologic assessment during a randomized trial of chemo-immunotherapy in acute myelogenous leukemia. Cancer Immunol Immunother 11:97–107, 1981.

    Article  Google Scholar 

  45. Obion D, Weiner R, Kramer B, Ross W, Noyes W, Kitchens C: Brief, intensive chemotherapy without maintenance therapy for acute myelogenous leukemia (AML): A SECSG Pilot Study. AACR Proc 23:114, 1982.

    Google Scholar 

  46. Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, Vassal F: Active immunotherapy for acute lymphoblastic leukemia. Lancet 1:697–699, 1969.

    Article  PubMed  Google Scholar 

  47. Powles Rl, Russell J, Lister TA, Oliver T, Whitehouse JMA, Malpas J, Chapuis B, Crowther D, Alexander P: Immunotherapy for acute myelogenous leukemia: A controlled clinical study two and a half years after entry of the last patient. Br J Cancer 35:265–272, 1977.

    Article  PubMed  CAS  Google Scholar 

  48. Galton DA, Peto R: Immunotherapy of acute myeloid leukaemia. Br J Cancer 37:1–14, 1978.

    Article  Google Scholar 

  49. Lindemalm C S-N, Killander A, Björkholm M, Brenning G, Engstedt L, Franzen S, Gahrton G, Gullbring B, Holm G, Höglund S, Hörnsten P, Jameson S, Killander D, Klein E, Lantz B, Lockner D, Lönngvist B, Mellstedt H, Palmblad J, Pauli C, Reizenstein P, Simonsson B, Skarberg K-O, Udén A-M, Vanky F, Wadman B: Adjuvant immunotherapy in acute non-lymphocytic leukemia. Cancer Immunol Immunother 4:179–183, 1978.

    Article  Google Scholar 

  50. Vuvan H, Fiere D, Doillon M, Martin C, Coiffier B, Felman P, Bryon PA, Favre-Gilly J, Revol L: BCG therapy inacute non-lymphoid leukaemias. Scan J Haematol 21:40–46, 1978.

    Article  CAS  Google Scholar 

  51. Vogler WR: Results of randomized trials of immunotherapy for acute leukemia. Cancer Immunol Immunother 9:15–21, 1980.

    Article  Google Scholar 

  52. Hewlett JS, Balcerzak S, Gutterman JU, Freireich EJ, Gehan EA, Kennedy A: Remission maintenance in adult acute leukemia with and without BCG. A Southwest Oncology Group Study. In: Immunotherapy of Cancer: Present Status of Trials in Man, Terry WD, Windhorst D (eds). Raven Press, NY, NY, 6:383–391, 1978.

    Google Scholar 

  53. Mandelli F, Amadori S, Dini E, Gringnani F, Leoni P, Liso V, Martelli M, Neri A, Petti MC, Ferrini PR: Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia. Leukemia Res 5:447–452, 1981.

    Article  CAS  Google Scholar 

  54. Zuhrie SR, Harris R, Freeman CB, MacIver JE, Geary CG, Delamore IW, Tooth JA: Immunotherapy alone vs no maintenance treatment in acute myelogenous leukemia. Br J Cancer 41:372–377, 1980.

    Article  PubMed  CAS  Google Scholar 

  55. Lister TA, Whitehouse JMA, Oliver RTD, Bell R, Johnson SAN, Wrigley PFM, Ford JM, Cullen MH, Gregory W, Paxton Am, Malpas JS: Chemotherapy and immunotherapy for acute Myelogenous leukemia. Cancer 46:2142–2148, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Vogler WR, Winton EF, Gordon DS, Raney MR, Go B, Meyer L: A randomized trial of post-remission therapy in acute myelogenous leukemia for the Southeastern Cancer Study Group. Blood 63:1039–1045, 1984.

    PubMed  CAS  Google Scholar 

  57. Cuttner J, Glidewell O, Holland JF, Bekesi JG: Chemoimmunotherapy of acute myelocytic leukemia with MER. In: Immunotherapy of Cancer: Present Status of Trials in Man, Terry WD, Windhorst D (eds). Raven Press, NY, NY, 6:405–413, 1978.

    Google Scholar 

  58. Mclntyre Or, Rai K, Glidewell O, Holland JF: Polyriboinosinic: polyribocytidylic acid as an adjunct to remission maintenance therapy in acute myelogenous leukemia. In: Immunotherapy of Cancer: Present Status of Trials in Man, Terry WD, Windhorst D (eds). Raven Press, NY, NY, 6:423–440, 1978.

    Google Scholar 

  59. Ohno R, Ueda U, Imai K, Kato Y, Watanabe E, Morishima Y, Yokomaku S, Kobayashi M, Takeyama H, Ezaki K, Kawashima K, Hirano M, Ohara K, Kosaki T, Yoshikawa S, Yamada K: A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia. Gann 69:179–186, 1978.

    Google Scholar 

  60. Eppinger-Helft M, Pavlovsky S, Hidalgo G, Muriel FS, Suarez A, Garay G, Russo C, Santos M, Macchi A, Lein J: Chemoimmunotherapy with corynebacterium parvum in acute myelocytic leukemia. Cancer 45:280–284, 1980.

    Article  PubMed  CAS  Google Scholar 

  61. Sauter C, Cavalli F, Lindenmann J, Gmur JP, Berchtold W, Alberto P, Obrecht P, Senn HJ: Viral oncolysis: Its application in maintenance treatment of acute Myelogenous leukemia. In: Immunotherapy of Cancer: Present Status of Trials in Man, Terry WD, Windhorst D (eds). Raven Press, NY, NY, 1978, pp 355–363.

    Google Scholar 

  62. Bekesi JG, Holland JF, Cuttner J, Silver R, Colman M: Immunotherapy of acute myelocytic leukemia with neuraminidase modified myeloblasts as immunogen. Proc ASCO 1:36, 1982.

    Google Scholar 

  63. Miller RA, Maloney DG, McKillop J, Levy R: In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 58:78–86, 1981.

    PubMed  CAS  Google Scholar 

  64. Raso V, Ritz J, Basala M, Schlossman SF: Monoclonal antibodyricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic antigen. Cancer Res 42:457–464, 1982.

    PubMed  CAS  Google Scholar 

  65. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 52:203–233, 1965.

    PubMed  CAS  Google Scholar 

  66. Cox DR: The analysis of binary data. Metheun, London, 1970.

    Google Scholar 

  67. Cox DR: Regression models and life tables (with discussion). J Roy Statist Soc B 34:187–220, 1972.

    Google Scholar 

  68. Breslow NE. Covariance analysis of censored survival data. Biometrics 38:89–99, 1974.

    Article  Google Scholar 

  69. Keating MJ, Smith TL, Gehan EA, McCredie KB, Bodey GP, Spitzer G, Hersh E, Gutterman J, Freireich EJ. Factors related to length of complete remission in adult acute leukemia. Cancer 45:2017–2029, 1980.

    Article  PubMed  CAS  Google Scholar 

  70. Passe S, Mike V, Mertelsmann R, Gee TS, Clarkson BD: Acute nonlymphoblastic leukemia: Prognostic factors in adults with long-term follow-up. Cancer 50:1462–1471, 1982.

    Article  PubMed  CAS  Google Scholar 

  71. Keating MJ, McCredie KB, Bodey GP, Smith TL, Gehan E, Freireich EJ: Improved prospects for long-term survival in adults with acute myelogenous leukemia. JAMA 248:2481–2486, 1982.

    Article  PubMed  CAS  Google Scholar 

  72. Brandman J, Bukowski RM, Greenstreet R, Hewlett JS, Hoffman GC: Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia. Cancer 44:1062–1065, 1979.

    Article  PubMed  CAS  Google Scholar 

  73. Vaughan WP, Karp JE, Burke PJ: Long chemotherapy-free remission after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia. Cancer 45:859–865, 1980.

    Article  PubMed  CAS  Google Scholar 

  74. Wolk RW, Masse SR, Conklin R, Freireich EJ: The incidence of central nervous system leukemia in adults with acute leuekmia. Cancer 33:863–869, 1974.

    Article  PubMed  CAS  Google Scholar 

  75. Pavlovsky S, Eppinger-Helft M, Muriel FS: Factors that influence the appearance of central nervous system leukemia. Blood 42:935–938, 1973.

    PubMed  CAS  Google Scholar 

  76. Wiernik PH, Schimpff SC, Schiffer CA, Lichtenfeld JL, Aisner J, O’Connell MJ, Dortner C: Randomized clinical comparision of daunorubicin (NDS-82151) alone with a combination of daunorubicin, cystosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia. Cancer Treat Rep 60:41–55, 1976.

    PubMed  CAS  Google Scholar 

  77. Meyer RJ, Ferreira PPC, Cuttner J, Greenberg ML, Goldberg J, Holland JF: Central nervous system involvement at presentation in acute granulocytic leukemia: A prospective cytocentrifuge study. Amer J Med 68:691–694, 1980.

    Article  PubMed  CAS  Google Scholar 

  78. Dahl GV, Simone JV, Hustu O, Mason C: Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia. Cancer 42:2187–2192, 1978.

    Article  PubMed  CAS  Google Scholar 

  79. Law IP, Blom J: Adult acute leukemia. Frequency of central nervous system involvement in long term survivors. Cancer 40:1304–1306, 1977.

    Article  PubMed  CAS  Google Scholar 

  80. Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49:511–535, 1977.

    PubMed  CAS  Google Scholar 

  81. UCLA Bone-Marrow Transplant Team. Bone marrow transplantation in acute leukemia. Lancet 2:1197–1200, 1977.

    Google Scholar 

  82. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute nonlym-phoblastic leukemia in first remission. N Engl J Med 301:597–599, 1979.

    Article  PubMed  CAS  Google Scholar 

  83. Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner A, Wolf JL: Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 302:1041–1046, 1980.

    Article  PubMed  CAS  Google Scholar 

  84. Gale RP, Kay HEM, Rimm AA, Bortin M. Bone-marrow transplantation for acute leukaemia in first remission. Lancet 2:1006–1009, 1982.

    Article  PubMed  CAS  Google Scholar 

  85. Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HEM, McElwain TJ: The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet 1:1047–1050, 1980.

    Article  PubMed  CAS  Google Scholar 

  86. Thomas ED, Clift RA, Buckner CD: Marrow transplantation for patients with acute non-lymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 66:1463–1466, 1982.

    PubMed  CAS  Google Scholar 

  87. Forman SJ, Spruce WE, Farbstein MJ, Wolf JL, Scott EP, Nademanee AP, Fahey L, Hecht T, Zaia JA, Krance RA, Findley DO, Blume KG: Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood 61:439–442, 1983.

    PubMed  CAS  Google Scholar 

  88. Reisner Y, Kirkpatrick D, Dupont B, Kapoor N, Pollack MS, Good RA, O’Reilly RJ: Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 2:327–331, 1981.

    Article  PubMed  CAS  Google Scholar 

  89. Powles RL, Morgenstern GR, Kay HEM, McElwain TJ, Clink HM, Dady PJ, Barrett A, Jameson B, Depledge MH, Watson JG, Sloane J, Leigh M, Lumley H, Hedley D, Lawler SD, Filshie J, Robinson B: Mismatched family donors for bone-marrow transplantation as treatment for acute leukemia. Lancet 1:612–615, 1983.

    Article  PubMed  CAS  Google Scholar 

  90. Beatty PG, Clift RA, Hansen JA, Mickelson EM, Nisperos B, Thomas ED: Marrow transplantation from donors other than HLA genotypically identical siblings. Proc ASCO 2:178, 1983.

    Google Scholar 

  91. Appelbaum FR, Cheever MA, Fefer A, Greenberg PD, Glucksberg H, Buckner CD, Thomas ED: A prospective study of the value of maintenance therapy or bone marrow transplantation (BMT) in adult acute nonlymphoblastic leukemia (AML). Blood 60:163a, 1982.

    Google Scholar 

  92. Champlin R, Zighelboim J, Ho W, Feig S, Boccia R, Gale RP, Winston D: Treatment of acute myelogenous leukemia (AML)-bone marrow transplantation (BMT) versus consolidation chemotherapy. Proc ASCO 2:180, 1983.

    Google Scholar 

  93. Herzig GP, Phillips GL, Mill W, NaPombejara C, Bernard S, Wolff S: Treatment of hematologic malignancy with cyclophosphamide (CY), total body irradiation (TBI) and autologous bone marrow transplantation (BMTX). Blood 52:253, 1978.

    Google Scholar 

  94. Dicke KA, McCredie KB, Spitzer G, Zander A, Peters L, Verma DS, Stewart D, Keating M, Stevens EE: Autologous bone marrow transplantation in patients with adult acute leukemia in relapse. Transplantation 26:169–173, 1978.

    Article  PubMed  CAS  Google Scholar 

  95. Gorin NC, Najman A, Salmon C, Muller JY, Petit JC, David R, Stachowiak J, Marie FH, Parlier Y, Duhamel G: High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: Kinetics of recovery of haemopoiesis. A preliminary study of 12 cases. Europ J Cancer 15:1113–1119, 1979.

    Article  CAS  Google Scholar 

  96. Zander AR, Vellekoop L, Spitzer G, Verma DS, Litam J, McCredie KB, Keating M, Hester JP, Dicke KA: Combination of high-dose cyclophosphamide, BCNU, and VP-16–213 followed by autologous marrow rescue in the treatment of relapsed leukemia. Cancer Treat Rep 65:377–381, 1981.

    PubMed  CAS  Google Scholar 

  97. Ritz J, Sallan SE, Bast RC Jr, Lipton JM, Clavell LA, Feeney M, Hercend T, Nathan DG, Schlossman SF. Autologous bone-marrow transplantation in calla-positive acute lymphoblastic leukaemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 2:60–63, 1982.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. William R. Vogler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Medical Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA

    Clara D. Bloomfield

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Vogler, W.R. (1985). Post-Remission Therapy for Acute Myelogenous Leukemia. In: Bloomfield, C.D. (eds) Chronic and Acute Leukemias in Adults. Cancer Treatment and Research, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2581-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2581-9_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9619-5

  • Online ISBN: 978-1-4613-2581-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation